Helicobacter pylori, or H. pylori, is one of the most common chronic bacterial infections in the world. As the main cause of peptic ulcer disease and a major risk factor for gastric cancer, H. pylori can lead to life-threatening medical conditions if left untreated. Timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm.
Helicobacter pylori Test menu
Due to the rising prevalence of antimicrobial resistance, understanding who to test and how to select the best treatment for H. pylori poses clinical challenges for healthcare providers. We offer a noninvasive option for the molecular detection of H. pylori using a single fecal specimen. This test:
Key testing
Highlights
Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.
In this month’s Hot Topic, Robin Patel, M.D., discusses Mayo Clinic Laboratories’ new PCR assay for detection of Helicobacter pylori detection and determination of clarithromycin resistance directly from stool.